Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway

Fig. 3

The effects of slc10a2 on invasion of A549 cells treated with bexarotene. a The invasion behavior of A549 cells treated with bexarotene, bexarotene + slc10a2-shRNA, bexarotene + slc10a2-overexpression respectively, A549 cells without any treatment as control group. b The quantification of migratory A549 cells treated with bexarotene, bexarotene + slc10a2-shRNA, bexarotene + slc10a2-overexpression respectively. All experiments were repeated 3 times. ***p < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us